Navigation Links
Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
Date:10/5/2007

-- conference call and audio web cast on October 9, 2007 --

BELLEVILLE, ON, Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company (TSX:BNC), will be discussing the U.S. Department of Agriculture (USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine during a:

Conference Call & Audio Web Cast

Tuesday, October 9, 2007

9:00 a.m. (Eastern)

To participate in the teleconference, call 416-644-3414/toll-free 1-800-733-7571.

A listen-only audio web cast will be available at:

http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2039180 (English)

http://www.cnw.ca/fr/webcast/viewEvent.cgi?eventID=2039180 (French)

A replay of the conference call will be available until October 16, 2007 by calling (416) 640-1917 or toll-free 1-877-289-8525 (passcode: 21249516 followed by the number sign).

The web cast will be available for replay using the above links until January 9, 2008.

About Bioniche Life Sciences

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 195 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. For more information, please visit http://www.Bioniche.com.


'/>"/>
SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
2. Scientist Calls Upon Media To Retract His Work
3. Rabies Requires Immediate Treatment
4. Media Messages Can Serve To Reduce Smoking Indoors
5. Media Plays Crucial Role In Flu Vaccinations
6. Chronic shortage of GPs in Australia, Need for Immediate Intervention
7. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
8. Medias Plays Vital Role In Sexual Behavior Of Teenagers
9. Immediate Attention Is Needed To Tackle the Obesity Crisis among Children
10. Long Term Mediation Not Advisable To Treat Hot Flashes
11. PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: